| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_02ac9bd35856d8efcae5699b55f9a19c |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-324
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2400-427 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-99
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23K10-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-135 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-135
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23K10-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-99 |
| filingDate |
2017-08-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fd1be8a85f64adc4646d6f29365d0925
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1f659e3d422886a70220f892056ecba3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0507cf3631d65d123b0b38f538443f6b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e26c0cfc65ff27d34f69667f4bde5a88
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_58fee21d34d12c3a5f26bcc08cdf7a7a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_164f2f3ca81bbbf342955163bfafceb8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_67b741551772320764c8b08c2ec33396
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_07fc07403a3cd40e95d5db63cef2244c |
| publicationDate |
2018-02-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2018034492-A1 |
| titleOfInvention |
Composition for preventing, ameliorating, or treating th1-mediated immune disease, th17-mediated immune disease, or th2-mediated immune disease comprising pediococcus pentosaceus as active ingredient |
| abstract |
The present invention relates to a composition for preventing, ameliorating, or treating a Th1-mediated immune disease, a Th17-mediated immune disease, or a Th2-mediated immune disease, the composition comprising Pediococcus pentosaceus as an active ingredient. The Pediococcus pentosaceus of the present invention induces regulatory T cells; regulates the ratio of the immune tolerant cytokine (IL-10; anti-inflammatory cytokine) to the immune activating cytokine (IL-12); and effectively controls a Th1-mediated immune disease, a Th17-mediated immune disease or a Th2-mediated immune disease by reducing Th1-related cytokines, Th17-related cytokines and Th2-related cytokines in the production of immunoglobulin E (IgE) and immune hypersensitive response, and therefore has an advantage that can be used as an anti-allergic composition and an anti-inflammatory composition. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111345345-A |
| priorityDate |
2015-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |